NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637955. A total of 1 filers reported holding NABRIVA THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,000 | 0.0% | 2,200 | +10.0% | 0.00% | – |
| Q2 2020 | $1,000 | -85.7% | 2,000 | -82.3% | 0.00% | – |
| Q1 2020 | $7,000 | -61.1% | 11,300 | -18.1% | 0.00% | – |
| Q4 2019 | $18,000 | -10.0% | 13,800 | +40.8% | 0.00% | – |
| Q3 2019 | $20,000 | -35.5% | 9,800 | -23.4% | 0.00% | – |
| Q2 2019 | $31,000 | – | 12,800 | +12700.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 100 | -90.9% | 0.00% | – |
| Q3 2018 | $3,000 | -40.0% | 1,100 | -15.4% | 0.00% | – |
| Q2 2018 | $5,000 | -54.5% | 1,300 | -40.9% | 0.00% | – |
| Q1 2018 | $11,000 | -15.4% | 2,200 | +4.8% | 0.00% | – |
| Q4 2017 | $13,000 | – | 2,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |